Purchases and Sales Made in Q3 2022 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q3 2022. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
39.6KNew |
$163K - $232K
|
39.6K
$49.4K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
20.7KNew |
$85.2K - $122K
|
20.7K
$25.9K
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
20.7KNew |
$85.2K - $122K
|
20.7K
$25.9K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
13.5K+ 73.39% |
$55.4K - $79.2K
|
31.9K
$39.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
11.8K+ 36.03% |
$48.5K - $69.2K
|
44.5K
$55.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
5.68K+ 45.91% |
$23.3K - $33.3K
|
18.1K
$22.6K
|
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
821+ 19.07% |
$3.37K - $4.82K
|
5.13K
$6.41K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 03, 2022
Q3 2022
|
Srs Capital Advisors, Inc.
Denver, CO |
SELL
|
- |
-140Closed |
$575 - $822
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-465- 38.27% |
$1.91K - $2.73K
|
750
$938
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group Ltd.
Dublin, L2 |
SELL
|
- |
-1.7K- 7.74% |
$7K - $10K
|
20.3K
$25.4K
|
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-2.4K- 83.22% |
$9.86K - $14.1K
|
484
$605
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-5.3K- 8.26% |
$21.8K - $31.1K
|
58.9K
$73.6K
|